The Recall Desk

Manufacturer

Pharmacy Plus, Inc. dba Vital Care Compounder

54 recalls in our database name Pharmacy Plus, Inc. dba Vital Care Compounder as the manufacturing or recalling firm.

What the numbers show

Total
54
Critical
0
Severe
20
Most recent
2023-04-26

Of the 54 recalls from Pharmacy Plus, Inc. dba Vital Care Compounder we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 20 (37%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

26–50 of 54

  • HighFDA (Drugs)·D-0030-2023·2022-11-09

    Ceftazidime Intravitreal Solution Recalled for Sterility Assurance Failure

    Vital Care Compounder is recalling Ceftazidime intravitreal injection solutions due to manufacturing conditions that cannot guarantee product sterility. Affected lots were distributed to patients in Alabama, Louisiana, Mississippi, and Tennessee.

    Product
    CEFTAZIDIME INTRAVITREAL 2.25MG/0.1ML Solution, 0.5 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0037-2023·2022-11-09

    Injectable hormone medication recalled for sterility assurance failure

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling Medroxyprogesterone Acetate 300 mg/mL suspension due to lack of sterility assurance. The product was produced in a manner that cannot guarantee sterility of the injectable medication.

    Product
    MEDROXYPROGESTERONE ACETATE 300 MG/ML Suspension, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0040-2023·2022-11-09

    Moxifloxacin Preservative-Free Eye Drops Recalled for Sterility Assurance Failure

    Pharmacy Plus, Inc. is recalling Moxifloxacin 0.15 mg/0.1 mL preservative-free eye drops in 1 mL syringes due to lack of assured sterility. FDA inspection found the manufacturing process could not guarantee the product's sterility.

    Product
    MOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0033-2023·2022-11-09

    Glycerin Ophthalmic Drops Recalled Due to Sterility Manufacturing Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling Glycerin Ophthalmic Drops 98.5% Solution because manufacturing methods cannot guarantee the sterility of the product. Products affected are distributed in Alabama, Louisiana, Mississippi, and Tennessee.

    Product
    GLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0026-2023·2022-11-09

    Acetylcysteine eye drops recalled for sterility assurance defect

    Pharmacy Plus Inc. is recalling acetylcysteine 10% eye drop solution due to manufacturing issues that cannot guarantee sterility. Lot 66895 was distributed in Alabama, Louisiana, Mississippi, and Tennessee.

    Product
    ACETYLCYSTEINE OPTH 10% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0043-2023·2022-11-09

    Pharmacy Compounded Injection Recalled for Sterility Assurance Failure

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling a compounded injectable medication because manufacturing did not ensure sterility. The product was distributed in Alabama, Louisiana, Mississippi, and Tennessee.

    Product
    PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 150MG/10MG/100MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0046-2023·2022-11-09

    Injectable Papaverine/Phentolamine Recalled Due to Sterility Assurance Failure

    Pharmacy Plus, Inc. is recalling 242 vials of papaverine/phentolamine injection because FDA inspection found the products were produced in conditions that cannot guarantee sterility. The affected lots were distributed to AL, LA, MS, and TN.

    Product
    PAPAVERINE / PHENTOLAMINE INJECTION 150MG / 5MG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0051-2023·2022-11-09

    Prescription eye drops recalled due to sterility assurance defect

    Vital Care Compounder is recalling 378 droptainers of PRED ACETATE/GATIFLOXACIN eye drops distributed in AL, LA, MS, and TN due to inability to guarantee manufacturing sterility. No illnesses have been reported.

    Product
    PRED ACETATE / GATIFLOXACIN 1% / 0.5% SUSP, 10 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1529-2016·2016-10-05

    Vital Care Compounder Recalls Chlorpheniramine Maleate Due to Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 108 vials of Chlorpheniramine Maleate 10 mg/ml due to lack of assurance of sterility.

    Product
    Chlorpheniramine Maleate 10 mg/ml, 30 ml MDV, Rx, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1545-2016·2016-10-05

    FDA Recalls Vital Care Compounder Injection Due to Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling C-PAP/PHEN/PROST/ATROP 150/5/5 injection vials due to a lack of assurance of sterility.

    Product
    C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 10 ml vials contain 5.8 ml solution, Vital Care COMPOUNDER, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1548-2016·2016-10-05

    Vital Care Compounder Recalls Hyaluronidase Vials Due to Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 23 vials of Hyaluronidase due to a lack of assurance of sterility. The affected lot was distributed in Mississippi.

    Product
    Hyaluronidase, 150 u/ml, 10 ml SDV, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1546-2016·2016-10-05

    Vital Care Compounder Recalls Olopatadine Eye Drops for Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling Olopatadine 0.8% Ophthalmic Solution due to a lack of assurance of sterility.

    Product
    Olopatadine 0.8% Ophthalmic Solution, 3ml bottle, Rx, Vital Care Compounder, Hattiesburg, MS
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1532-2016·2016-10-05

    Vital Care Compounder Recalls Moxifloxacin and Dexamethasone Eye Drops

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling specific lots of Moxifloxacin and Dexamethasone ophthalmic vials due to a lack of assurance of sterility.

    Product
    Moxifloxacin 0.5% + Dexamethazone 0.1%, 15ml vial Contains: Moxifloxacin 5mg/ml, Dexamethasone Sodium Phosphate 1mg/ml, Rx only, For ophthalmic use only, Vital Care Compounder, Hattiesburg, MS
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1538-2016·2016-10-05

    Vital Care Compounder Recalls Moxifloxacin HCl Eye Drops for Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 16 vials of Moxifloxacin HCl eye drops due to a lack of assurance of sterility.

    Product
    Moxifloxacin HCl 1 mg/ml (0.1mg/0.1ml) and BSS solution, 2ml Single use vial, Rx, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1543-2016·2016-10-05

    FDA Recalls Pre-Op Pledget Soln + Tetracaine Due to Sterility Concerns

    Pharmacy Plus, Inc. is recalling Pre-Op Pledget Soln + Tetracaine vials because the agency cannot ensure the product is sterile.

    Product
    Pre-Op Pledget Soln + Tetracaine, (Tropicamide (1%) 0.47ml, Phenylephrine (10%) 0.93ml, Ketorolac (0.5%) 0.47l, Ofloxacin (0.3) 0.95, Tetracaine (0.5%), 3ml vial, Rx, Vital Care Compounder, Hattiesburg, MS
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1547-2016·2016-10-05

    FDA Recalls Vital Care Compounder Injection Due to Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling C-PAP/PHEN/PROST/Atrop 150/7.5 injection vials due to a lack of assurance of sterility.

    Product
    C-PAP/PHEN/PROST/Atrop 150/7.5 (Papaverine 150mg/Phentolamine 7.5mg/Prostaglandin 75mcg/Atropine 1mg injection), 10 ml vial containing 5.9ml solution, Rx, Vital Care Compounder, Hattiesburg, MS
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1542-2016·2016-10-05

    FDA Recalls Pre-Op Pledget Ophthalmic Drops Due to Sterility Concerns

    Pharmacy Plus, Inc. is recalling Pre-Op Pledget Soln ophthalmic drops due to a lack of assurance of sterility. The recall affects 6 vials distributed in Mississippi.

    Product
    Pre-Op Pledget Soln, Ophthalmic Drops (Tropicamide (1%) 0.33ml, Phenylephrine (10%) 0.66ml, Ketorolac (0.5%) 0.33ml, Ofloxacin (0.3) 0.67ml, 2ml vial, Rx, Vital Care Compounder, Hattiesburg, MS
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1535-2016·2016-10-05

    FDA Recalls Vital Care Compounder Papaverine and Prostaglandin Vials for Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling specific lots of Papaverine and Prostaglandin vials due to a lack of assurance of sterility.

    Product
    Papaverine 150 mg/Phentolamine 5 mg and Prostaglandin 50 mcg, packaged as 5.5 mL in a 10 mL MDV, Rx only, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1533-2016·2016-10-05

    FDA Recalls Vital Care Compounder Eye Drops for Sterility Concerns

    The FDA is recalling specific lots of MOXI/DEX/KETOROLAC eye drops from Vital Care Compounder due to a lack of assurance of sterility.

    Product
    MOXI/DEX/KETOROLAC 0.5%/0.1%/0.4%, #15, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1534-2016·2016-10-05

    Vital Care Compounder Recalls Papaverine and Phentolamine Vials Due to Sterility Concerns

    Pharmacy Plus, Inc. dba Vital Care Compounder is recalling specific lots of Papaverine 150 mg / Phentolamine 5 mg vials due to a lack of assurance of sterility.

    Product
    Papaverine 150 mg / Phentolamine 5 mg vials, packaged 5.5 mL in a sterile, clear 10 mL MDV, Rx only, Sterile Injection, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1539-2016·2016-10-05

    Morphine Sulfate Injection Recalled for Lack of Sterility Assurance

    Pharmacy Plus, Inc. is recalling Morphine Sulfate 15mg/ml Injection due to a lack of assurance of sterility. The product was distributed in Mississippi.

    Product
    Morphine Sulfate 15mg/ml Injection, 20 ml MDV, Rx, Vital Care Compounder, Hattiesburg, MS
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1541-2016·2016-10-05

    FDA Recalls Autologous Serum Tears Due to Sterility Assurance Concerns

    The FDA is recalling Autologous Serum Tears from Vital Care Compounder due to a lack of assurance of sterility. The product was distributed in Mississippi.

    Product
    Autologous Serum Tears, 2 vials, Rx, Vital Care Compounder, Hattiesburg, MS 39402
    Category
    Drug
    Distribution
    1 state